U.S. Markets closed

Digipath Names Jorge Restrepo To Lead Digipath Labs Colombia

Veteran Agronomist and Agriculture Leader Joins Digipath

BOGOTA, Colombia, Feb. 12, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data analytics and media firm focused on the developing cannabis and hemp markets, is pleased to announce that Jorge Restrepo has been hired to lead  Digipath's venture into the rapidly emerging Colombian market. Digipath is intent on positioning itself as one of the first cannabis-testing laboratories in Colombia.

(PRNewsfoto/DigiPath, Inc.)

Mr. Restrepo brings to Digipath a tremendous wealth of agricultural and management experience in the region. He has overseen significant Colombian and Central American agricultural research programs which set out to improve growing conditions in the nation. His important work has led to advancements in Latin American and African agriculture and the education of  students and farmers.

Mr. Restrepo is a Agronomist who graduated from Zamorano University, Honduras and also holds a Masters Degree in Public Administration from Harvard University, The Kennedy School of Government.

"Jorge Restrepo is the perfect ambassador for Digipath in Colombia," stated Todd Denkin, President and CEO, Digipath, Inc. "His background and education provide him with the essential tools to oversee this opportunity for us. We believe that his broad relationships with the business, agricultural and government sectors  will be essential catalysts to our expansion and success."

Mr. Restrepo's initial responsibilities will be to secure the necessary licensing and identify a suitable location for an approximately 5,000 square foot testing laboratory, sufficient to replicate Digipath Labs' proven model of quality and efficiency created in the United States.

"It is an honor to bring to Colombia one of the true leaders of the American cannabis economy," stated Restrepo. "Our country recognizes the opportunity that legal cannabis can provide. I am pleased to oversee this initiative that should benefit both Colombia and the shareholders of Digipath."

About Digipath, Inc. & Digipath Labs, Inc.

Digipath, Inc. supports the cannabis industry's best practices for reliable testing, data acquisition, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Digipath Labs provides pharmaceutical-grade analysis and testing to the cannabis industry to ensure producers, consumers, and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its client's products through analysis, research, development, and standardization.

Digipath Investor Relations & Financial Media

info@integrityir.com
Toll Free: (888) 216-3595
www.IntegrityIR.com

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting Digipath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

 

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/digipath-names-jorge-restrepo-to-lead-digipath-labs-colombia-300793877.html